| Secondary |
| Product Used For Unknown Indication |
30.6% |
| Drug Abuse |
19.3% |
| Drug Use For Unknown Indication |
7.5% |
| Antiemetic Supportive Care |
5.8% |
| Schizophrenia |
5.3% |
| Insomnia |
4.6% |
| Schizophrenia, Paranoid Type |
3.8% |
| Psychotic Disorder |
3.1% |
| Arthralgia |
3.1% |
| Depression |
2.7% |
| Mental Disorder |
2.3% |
| Prophylaxis Of Nausea And Vomiting |
1.9% |
| Schizoaffective Disorder |
1.8% |
| Aggression |
1.6% |
| Pain |
1.6% |
| Anxiolytic Therapy |
1.2% |
| Bipolar Disorder |
1.1% |
| Foetal Exposure During Pregnancy |
1.0% |
| Ill-defined Disorder |
0.8% |
| Affective Disorder |
0.8% |
|
| Toxicity To Various Agents |
10.6% |
| Vomiting |
9.6% |
| Ileus Paralytic |
8.7% |
| Hypothermia |
7.7% |
| Intra-uterine Death |
7.7% |
| Drug Interaction |
5.8% |
| Suicide Attempt |
5.8% |
| Weight Decreased |
5.8% |
| Extrapyramidal Disorder |
4.8% |
| Drug Ineffective |
3.8% |
| Musculoskeletal Stiffness |
3.8% |
| Overdose |
3.8% |
| Akathisia |
2.9% |
| Cachexia |
2.9% |
| Miosis |
2.9% |
| Sopor |
2.9% |
| Stupor |
2.9% |
| Sudden Death |
2.9% |
| Weight Increased |
2.9% |
| Accidental Overdose |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
12.4% |
| Sarcoma Metastatic |
8.3% |
| Schizophrenia |
6.3% |
| Insomnia |
5.8% |
| Nausea |
5.5% |
| Tension |
5.1% |
| Depression |
4.5% |
| Prophylaxis |
4.1% |
| Rhabdomyosarcoma |
3.7% |
| Pain |
2.8% |
| Systemic Lupus Erythematosus |
2.6% |
| Hiv Infection |
2.5% |
| Cancer Pain |
2.4% |
| Prophylaxis Of Nausea And Vomiting |
2.1% |
| Sarcoma |
1.9% |
| Vomiting |
1.8% |
| Analgesic Therapy |
1.6% |
| Constipation |
1.6% |
| Hypothyroidism |
1.6% |
|
| Psychotic Disorder |
17.5% |
| Vomiting |
8.8% |
| Mucosal Inflammation |
8.3% |
| Respiratory Failure |
6.1% |
| Death |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Febrile Neutropenia |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Pleural Effusion |
4.4% |
| Progressive Multifocal Leukoencephalopathy |
3.9% |
| Toxic Epidermal Necrolysis |
3.9% |
| Weight Decreased |
3.9% |
| Drug Interaction |
3.1% |
| Epistaxis |
3.1% |
| Pulmonary Oedema |
3.1% |
| Sinus Arrhythmia |
3.1% |
| Candida Test Positive |
2.6% |
| Colitis |
2.6% |
| Dry Eye |
2.6% |
| Infection |
2.6% |
|
| Interacting |
| Ill-defined Disorder |
15.8% |
| Schizophrenia |
14.0% |
| Depression |
11.0% |
| Drug Use For Unknown Indication |
7.9% |
| Pneumonia |
7.0% |
| Antiemetic Supportive Care |
4.4% |
| Pneumonia Aspiration |
4.4% |
| Procedural Pain |
4.4% |
| Anxiety |
3.5% |
| Constipation |
3.5% |
| Psychotic Disorder |
3.5% |
| Attention Deficit/hyperactivity Disorder |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Agitation |
2.6% |
| Intentional Overdose |
2.6% |
| Drug Dependence |
2.2% |
| Hypervigilance |
2.2% |
| Mental Disorder |
1.8% |
| Sleep Disorder Therapy |
1.8% |
| Ankle Fracture |
1.3% |
|
| Neuroleptic Malignant Syndrome |
20.7% |
| Drug Interaction |
13.8% |
| Miosis |
10.3% |
| Serotonin Syndrome |
10.3% |
| Akathisia |
6.9% |
| Decreased Appetite |
6.9% |
| Weight Decreased |
6.9% |
| Depressed Level Of Consciousness |
3.4% |
| Ileus Paralytic |
3.4% |
| Long Qt Syndrome |
3.4% |
| Nausea |
3.4% |
| Sepsis |
3.4% |
| Somnolence |
3.4% |
| Urinary Incontinence |
3.4% |
|
